Myrella Vlenterie

Apeldoorn, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Cost-Effectiveness of the STEPS Work Participation Program Compared to Usual Care, for Cancer Survivors: An Economic Evaluation Alongside a Randomized Controlled Trial.

Cost-Effectiveness of the STEPS Work Participation Program Compared to Usual Care, for Cancer Survivors: An Economic Evaluation Alongside a Randomized Controlled Trial.

Journal: Journal of occupational rehabilitation

Published: March 13, 2026

SusTained Employability in cancer Patients and their partnerS: Results of a Randomized Controlled Trial into the Effectiveness of the STEPS Program.

SusTained Employability in cancer Patients and their partnerS: Results of a Randomized Controlled Trial into the Effectiveness of the STEPS Program.

Journal: Journal of occupational rehabilitation

Published: March 05, 2026

Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma.

Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma.

Journal: Frontiers in oncology

Published: August 06, 2022

Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas.

Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas.

Journal: Anticancer research

Published: January 06, 2019

Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes.

Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes.

Journal: Cancer research

Published: September 19, 2016

Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.

Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 22, 2016

Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients.

Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients.

Journal: Annals of surgical oncology

Published: January 15, 2016

Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [18F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tumours: All that glitters is not gold.

Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [18F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tumours: All that glitters is not gold.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 27, 2015

Prevalence, Impact, and Correlates of Severe Fatigue in Patients With Gastrointestinal Stromal Tumors.

Prevalence, Impact, and Correlates of Severe Fatigue in Patients With Gastrointestinal Stromal Tumors.

Journal: Journal of pain and symptom management

Published: November 17, 2015

Next generation sequencing in synovial sarcoma reveals novel gene mutations.

Next generation sequencing in synovial sarcoma reveals novel gene mutations.

Journal: Oncotarget

Published: June 21, 2015

Synovial sarcoma diagnosis and management in the era of targeted therapies.

Synovial sarcoma diagnosis and management in the era of targeted therapies.

Journal: Current opinion in oncology

Published: June 08, 2015

Age as an independent prognostic factor for survival of localised synovial sarcoma patients.

Age as an independent prognostic factor for survival of localised synovial sarcoma patients.

Journal: British journal of cancer

Published: May 07, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026